Regulation of apoptosis by type III interferons

被引:89
作者
Li, W. [1 ]
Lewis-Antes, A. [1 ]
Huang, J. [1 ]
Balan, M. [1 ]
Kotenko, S. V. [1 ]
机构
[1] Univ Med & Dent New Jersey, Univ Hosp Canc Ctr, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
关键词
D O I
10.1111/j.1365-2184.2008.00558.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Two types of interferons (IFNs), type I (IFN-alpha/beta) and type III (IFN-lambda s), utilize distinct receptor complexes to induce similar signalling and biological activities, including recently demonstrated for IFN-lambda s antitumour activity. However, ability of type III IFNs to regulate cell population growth remains largely uncharacterized.Materials and methods: Intact and modified human colorectal adenocarcinoma HT29 cells were used to study regulation of apoptosis by IFN-lambda s. Results and Conclusions: We report that the IFN-lambda R1 chain of the type III IFN receptor complex possesses an intrinsic ability to trigger apoptosis in cells. Signalling induced through the intracellular domain of IFN-lambda R1 resulted in G(1)/G(0) phase cell cycle arrest, phosphatidylserine surfacing and chromosomal DNA fragmentation. Caspase-3, caspase-8 and caspase-9 were activated; however, pancaspase inhibitor Z-VAD-FMK did not prevent apoptosis. In addition, the extent of apoptosis correlated with the level of receptor expression and was associated with prolonged IFN-lambda signalling. We also demonstrated that the ability to trigger apoptosis is a unique intrinsic function of all IFN receptors. However, more robust apoptosis was induced by signalling through type III IFN receptor than through type I or type II (IFN-gamma) receptors, suggesting higher cytotoxic potential of type III IFNs. In addition, we observed that IFN-gamma treatment sensitized HT29 cells to IFN-lambda-mediated apoptosis. These results provide evidence that type III IFNs, alone or in combination with other stimuli, have the potential to induce apoptosis.
引用
收藏
页码:960 / 979
页数:20
相关论文
共 81 条
[1]   p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage [J].
Bissonnette, N ;
Hunting, DJ .
ONCOGENE, 1998, 16 (26) :3461-3469
[2]   Interleukin 20: Discovery, receptor identification, and role in epidermal function [J].
Blumberg, H ;
Conklin, D ;
Xu, WF ;
Grossmann, A ;
Brender, T ;
Carollo, S ;
Eagan, M ;
Foster, D ;
Haldeman, BA ;
Hammond, A ;
Haugen, H ;
Jelinek, L ;
Kelly, JD ;
Madden, K ;
Maurer, MF ;
Parrish-Novak, J ;
Prunkard, D ;
Sexson, S ;
Sprecher, C ;
Waggie, K ;
West, J ;
Whitmore, TE ;
Yao, L ;
Kuechle, MK ;
Dale, BA ;
Chandrasekher, YA .
CELL, 2001, 104 (01) :9-19
[3]   Milstein Award Lecture: Interferons and cancer: Where from here? [J].
Borden, EC .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (09) :511-527
[4]   IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression [J].
Brand, S ;
Beigel, F ;
Olszak, T ;
Zitzmann, K ;
Eichhorst, ST ;
Otte, JM ;
Diebold, J ;
Diepolder, H ;
Adler, B ;
Auernhammer, CJ ;
Göke, B ;
Dambacher, J .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 289 (05) :G960-G968
[5]   Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis [J].
Chawla-Sarkar, M ;
Lindner, DJ ;
Liu, YF ;
Williams, B ;
Sen, GC ;
Silverman, RH ;
Borden, EC .
APOPTOSIS, 2003, 8 (03) :237-249
[6]   Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced in multiple myeloma [J].
Chen, Q ;
Gong, B ;
Mahmoud-Ahmed, AS ;
Zhou, A ;
Hsi, ED ;
Hussein, M ;
Almasan, A .
BLOOD, 2001, 98 (07) :2183-2192
[7]   Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21(WAF1/CIP1) mediated by STAT1 [J].
Chin, YE ;
Kitagawa, M ;
Su, WCS ;
You, ZH ;
Iwamoto, Y ;
Fu, XY .
SCIENCE, 1996, 272 (5262) :719-722
[8]   Interferons and apoptosis [J].
Clemens, MJ .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (06) :277-292
[9]   Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays [J].
Der, SD ;
Zhou, AM ;
Williams, BRG ;
Silverman, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15623-15628
[10]   Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes [J].
Doyle, Sean E. ;
Schreckhise, Heidi ;
Khuu-Duong, Kien ;
Henderson, Katherine ;
Rosler, Robert ;
Storey, Harold ;
Yao, Lena ;
Liu, Hong ;
Barahmand-pour, Fariba ;
Sivakumar, Pallavur ;
Chan, Chung ;
Birks, Carl ;
Foster, Don ;
Clegg, Christopher H. ;
Wietzke-Braun, Perdita ;
Mihm, Sabine ;
Klucher, Kevin M. .
HEPATOLOGY, 2006, 44 (04) :896-906